News

May 17, 2022

CRB’s Jeff Wegner and Maya DeHart dig into the shifting biopharma priorities of planet, profit and people.

Apr 28, 2022

Niranjan Kulkarni, PhD, Sr. Director Consulting Services, discusses strategies to overcome supply chain disruptions and improve production efficiencies to streamline operations.

Mar 21, 2022

Third edition addresses significant changes in food + beverage aseptic processing and packaging

Mar 9, 2022

Kris Desmet joins CRB’s growing SlateXpace leadership team

Feb 22, 2022

CRB’s Lean execution method champions Mike Barrett and Carl Rohs provide insight into the benefits of a Lean project delivery approach as well as the barriers to implementation.

Feb 22, 2022

Melisa Vasquez, will be speaking on CRB case studies at The Last Planner System Conference on March 2, 2022.

Feb 15, 2022

CRB has appointed Courtney Holt as General Counsel. Holt succeeds Jim Scott, who will retire later this year after eight years as CRB’s in-house counsel and several years before that as outside counsel.

Feb 3, 2022

Dennis Collins, AIA, Architectural Group Leader and Senior Associate, discusses how to improve the employee experience amid the current labor shortage.

Jan 28, 2022

Industry 4.0 expert, Yvonne Duckworth, provides insight into the pharmaceutical industry’s recent digital advancements.

Jan 7, 2022

Twenty-three-year CRB veteran Paul Skinner, PE, promoted as Tim Henquinet, existing CFO, announces his pending retirement after nearly a decade of service.

Dec 20, 2021

CRB’s AL Nesbitt and Brian Belvin will lead a webinar that explores how they were able to evolve their processes and techniques to effectively execute pull planning with a virtual team.

Dec 14, 2021

Arrival of longtime construction leader Steve Morton enhances company’s successful ONEsolution™ approach.

Dec 13, 2021

The Association of Dressings & Sauces (ADS) reappointed Ben Rucker to the Executive Technical Board for an additional two years.

Dec 3, 2021

Join ISPE and CRB’s Yvonne Duckworth for a free webinar on the evolving landscape of Pharma 4.0™.

Nov 29, 2021

Christa Myers shares tips for owning your value, setting and reaching goals and celebrating professional success with the Women in Pharma community.

Nov 19, 2021

CRB’s Yvonne Duckworth and Niranjan Kulkarni provide expert insight into the quality, speed, and operational efficiencies Pharma 4.0™ offers clinical trials.

Nov 19, 2021

CRB’s Charles Heffernan joins several industry experts as they look back at 20 years of industry breakthroughs and into the shifting priorities of the future.

Oct 22, 2021

Rob Boulanger, Marc Pelletier and Alejandro Kaiser examine the source of contaminated cell cultures in a detailed case study.

Oct 21, 2021

CRB’s Marc Hanson and Greg Casper interviewed for Engineering News-Record’s (ENR) cost report.

Oct 11, 2021

Hosting our annual educational series, Tech Tank, CRB’s subject matter experts will speak to critical, relevant topics in pharmaceutical manufacturing at INTERPHEX 2021.

Sep 1, 2021

CRB’s Mike Politi joined trade partners to discuss the critical elements of successful integrated project delivery.

Aug 12, 2021

CRB’s Yvonne Duckworth interviewed for “Trends in Digitalization of Pharma Manufacturing” in Pharmaceutical Technology.

Aug 2, 2021

CRB’s Mike Barrett interviewed for “Facility Expansions Are on the Rise” in Genetic Engineering and Biotechnology News (GEN).

Jun 23, 2021

Peter Walters and Noel Maestre dig into the design factors influencing multimodal manufacturing within cell and gene therapy.

May 26, 2021

We’re excited to announce that Alan Jones has joined the company as our new Vice President of Business Development. Jones – who has deep experience in establishing long-term client relationships across design, construction, manufacturing and other industries – will report to Lance Nordbak, CRB’s Chief Operating Officer for Regional Operations.  

May 19, 2021

Join Yvonne Duckworth as she discusses current trends, benefits and challenges of Pharma 4.0.

May 12, 2021

Allan Bream and Brita Salzmann take a deep dive into the mounting challenges of commercially manufacturing cell and gene therapies.

May 12, 2021

JP Bornholdt was recently featured in BioBuzz. The article assesses challenges within biotech manufacturing and the growing need for facility flexibility.

Apr 19, 2021

JP Bornholdt was recently featured in Pharmaceutical Manufacturing. In this article, he discusses SlateXpace, a CRB solution, in regards to pharma’s quest to attain ultimate flexibility.

Feb 26, 2021

CRB earns a mention in “Wanted: More high-tech manufacturing space for a global vaccine push.”

Jan 29, 2021

What can the industry learn from the global COVID-response to incorporate into pet food processing facility design?

Jan 25, 2021

Higley’s credentials across food & beverage advance company’s goal of becoming preeminent provider of manufacturing solutions

Jan 19, 2021

Peter Walters and JP Bornholdt discuss modular flexibility in the manufacturing multiverse.

Dec 7, 2020

Peter Walters, Director of ATMP, discusses modular facility design and why flexibility is paramount for the current manufacturing industry.

Nov 30, 2020

Myers and Pelletier discuss the components to a strong regulatory strategy that can help ensure future rapid response.

Nov 18, 2020

Dr. Dutton offers GMP design and compliance services to CRB’s Canadian clients.

Nov 5, 2020

Tony Moses, a process engineer with CRB’s Omaha office, was recently appointed to serve as a director on the Aksarben Institute of Food Technologists (IFT) Board.

Oct 20, 2020

Allan Bream is featured in BioProcess International with his article, “Trends in Facility Design—In-House Manufacturing Considerations for Cell and Gene Therapy Production.”

Oct 1, 2020

Jarrod Wrampe’s Five Ways to Achieve Warp Speed featured in Contract Pharma.

Sep 17, 2020

Elliott will direct all aspects of project delivery – from lean and safety emphasis through to quality control and customer experience.

Sep 17, 2020

Are you ready for robotics?

Aug 18, 2020

What will the laboratory of the future look like, especially when dealing with post-COVID realities?